Ximelagatran (Exanta or Exarta H 376/95) is an anticoagulant that has been investigated extensively as a replacement for warfarin that would overcome the problematic dietary drug interaction and monitoring issues associated with warfarin therapy.
This page contains content from the copyrighted Wikipedia article "Ximelagatran"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.